Shares in Senseonics (NYSE:SENS) fell today even though the medical technology company beat expectations on Wall Street with its third quarter results.
The Germantown, Md.-based company posted a loss of -$17.4 million on sales of $2.1 million for the 3 months ended Sept. 30.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics tops sales estimates with Q3 results appeared first on MassDevice.